About Tympanogen
Tympanogen is a company based in Norfolk (United States) founded in 2014. Tympanogen has raised $2.18 million across 7 funding rounds from investors including HHS, Virginia Catalyst and Center for Innovative Technology. Tympanogen offers products and services including Perf-Fix. Tympanogen operates in a competitive market with competitors including AventaMed, Preceptis Medical, NousQ, Doya Medical and EntraTympanic, among others.
- Headquarter Norfolk, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tympanogen, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.18 M (USD)
in 7 rounds
-
Latest Funding Round
$1.16 M (USD), Seed
Feb 10, 2025
-
Investors
HHS
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tympanogen
Tympanogen offers a comprehensive portfolio of products and services, including Perf-Fix.
Nonsurgical treatment for eardrum repair using innovative gel system.
People of Tympanogen
Unlock access to complete
Unlock access to complete
Funding Insights of Tympanogen
Tympanogen has successfully raised a total of $2.18M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $1.16 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tympanogen
Tympanogen has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Virginia Catalyst and Center for Innovative Technology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage VC firm funding companies in the US
|
Locked | Locked | Locked | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked | |
|
Virginia Catalyst is focused on life sciences funding initiatives.
|
Locked | Locked | Locked |
Investor details for Tympanogen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tympanogen
Investment portfolio details for Tympanogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tympanogen
Detailed financials for Tympanogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tympanogen Comparisons
Peer comparison for Tympanogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tympanogen
Tympanogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AventaMed, Preceptis Medical, NousQ, Doya Medical and EntraTympanic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Device for safe placement of grommets
|
|
| Locked | Locked | Locked |
Surgical tools for pediatric ear tube procedures are developed.
|
|
| Locked | Locked | Locked |
Developer of a robotic surgical applicator for ear tube surgery. This device aims to simplify the procedure, reducing the need for general anesthesia and a surgical microscope. It enables outpatient settings and potentially reduces costs. The applicator uses commercially available ear tubes and features safety and precision enhancements through robotics and sensor technology. It makes a precise incision on the eardrum, improving outcomes for patients.
|
|
| Locked | Locked | Locked |
Develops non-invasive stent technology for treating otitis media with effusion.
|
|
| Locked | Locked | Locked |
Medical device for the treatment of middle ear infections
|
Detailed competitors of Tympanogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tympanogen
Complete news archive for Tympanogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tympanogen
Tympanogen was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Tympanogen is headquartered in Norfolk, United States. It is registered at Norfolk, Virginia, United States.
Tympanogen is a funded company, having raised a total of $2.18M across 7 funding rounds to date.
Provider of gel patch for chronic tympanic membrane perforations. The company develops products for chronic tympanic membrane perforations to treat middle ear infections which may result in hearing loss, nerve, and brain damage. Unlike the invasive surgical procedures, the companys patent-pending gel patch product called Perf-Fix is used in an in-clinic procedure; It promotes tissue regrowth, prevents infections.
Tympanogen's top competitors include Preceptis Medical, AventaMed and NousQ.
Tympanogen offers Perf-Fix.
Tympanogen has 4 investors. Key investors include HHS, Virginia Catalyst, Center for Innovative Technology, and MassChallenge.